Skip to main content
SpringerLink
Log in

V-Go device reduces diabetes management costs

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was performed by Diabetes America Texas, a large speciality health care system.

Reference

  • Valeritas. Study Analysis Shows Valeritas' V-Go(Rm) Device Helps Reduce Diabetes Management Cost for Type 2 Diabetes Patients by Improving Glycemic Control and Reducing Insulin Doses. Media Release : 9 Apr 2015. Available from: URL: http://www.valeritas.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

V-Go device reduces diabetes management costs. PharmacoEcon Outcomes News 726, 30 (2015). https://doi.org/10.1007/s40274-015-2078-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2078-x

Search

Navigation